Goals of workThe goals of the study were to determine the occurrence rates for and the severity of symptoms at the middle, end, and 1 month after the completion of radiation therapy (RT), to determine the number and types of symptom clusters at these three time points, and to evaluate for changes over time in these symptom clusters.Materials and methodsSymptom occurrence and severity were evaluated using the Memorial Symptom Assessment Scale (MSAS) in a sample of patients (n = 160) who underwent RT for breast or prostate cancer. At each time point, an exploratory factor analysis was done to determine the number of symptom clusters (i.e., symptom factors) based on the MSAS symptom severity ratings.Main resultsThe majority of the patients wer...
Problem. Patients with head and neck cancer (HNC) experience multiple concurrent treatment-related s...
Problem. Patients with head and neck cancer (HNC) experience multiple concurrent treatment-related s...
Purpose The aim was to prospectively map symptom clusters in patients with stage I–IIIa breast cance...
Goals of workThe goals of the study were to determine the occurrence rates for and the severity of s...
The goals of the study were to determine the occurrence rates for and the severity of symptoms at th...
Abstract Symptom clusters are stable groups of interrelated symptoms that occur simultaneously. Res...
Goals of work The goals of the study were to determine the occurrence rates for and the severity of ...
Context Research about clusters of symptoms in oncology is an emerging field of study. However, ther...
Context Research about clusters of symptoms in oncology is an emerging field of study. However, ther...
Purpose: Research on symptom clusters is a newly emerging field in oncology; however, little evidenc...
ABSTRACTSymptom Clusters in Patients With Breast Cancer Undergoing Chemotherapy The first study on s...
Symptom clusters research is an emerging field in oncology nursing, and little is known about sympto...
Symptom clusters are stable groups of interrelated symptoms occurring simultaneously. Research on sy...
Symptom clusters are stable groups of interrelated symptoms occurring simultaneously. Research on sy...
PurposeOne of the unanswered questions in symptom clusters research is whether the number and types ...
Problem. Patients with head and neck cancer (HNC) experience multiple concurrent treatment-related s...
Problem. Patients with head and neck cancer (HNC) experience multiple concurrent treatment-related s...
Purpose The aim was to prospectively map symptom clusters in patients with stage I–IIIa breast cance...
Goals of workThe goals of the study were to determine the occurrence rates for and the severity of s...
The goals of the study were to determine the occurrence rates for and the severity of symptoms at th...
Abstract Symptom clusters are stable groups of interrelated symptoms that occur simultaneously. Res...
Goals of work The goals of the study were to determine the occurrence rates for and the severity of ...
Context Research about clusters of symptoms in oncology is an emerging field of study. However, ther...
Context Research about clusters of symptoms in oncology is an emerging field of study. However, ther...
Purpose: Research on symptom clusters is a newly emerging field in oncology; however, little evidenc...
ABSTRACTSymptom Clusters in Patients With Breast Cancer Undergoing Chemotherapy The first study on s...
Symptom clusters research is an emerging field in oncology nursing, and little is known about sympto...
Symptom clusters are stable groups of interrelated symptoms occurring simultaneously. Research on sy...
Symptom clusters are stable groups of interrelated symptoms occurring simultaneously. Research on sy...
PurposeOne of the unanswered questions in symptom clusters research is whether the number and types ...
Problem. Patients with head and neck cancer (HNC) experience multiple concurrent treatment-related s...
Problem. Patients with head and neck cancer (HNC) experience multiple concurrent treatment-related s...
Purpose The aim was to prospectively map symptom clusters in patients with stage I–IIIa breast cance...